Aspire Dental Care Limited 06376349 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of dental services. Digita Accounts Production Advanced 6.30.9574.0 true true 06376349 2024-04-01 2025-03-31 06376349 2025-03-31 06376349 core:CurrentFinancialInstruments 2025-03-31 06376349 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06376349 core:FurnitureFittingsToolsEquipment 2025-03-31 06376349 core:LandBuildings 2025-03-31 06376349 bus:SmallEntities 2024-04-01 2025-03-31 06376349 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06376349 bus:FilletedAccounts 2024-04-01 2025-03-31 06376349 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 06376349 bus:RegisteredOffice 2024-04-01 2025-03-31 06376349 bus:CompanySecretary1 2024-04-01 2025-03-31 06376349 bus:CompanySecretaryDirector1 2024-04-01 2025-03-31 06376349 bus:Director2 2024-04-01 2025-03-31 06376349 bus:Director3 2024-04-01 2025-03-31 06376349 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06376349 bus:Agent1 2024-04-01 2025-03-31 06376349 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 06376349 core:LandBuildings 2024-04-01 2025-03-31 06376349 core:OtherRelatedPartyRelationshipType1ComponentTotalRelatedParties 2024-04-01 2025-03-31 06376349 countries:EnglandWales 2024-04-01 2025-03-31 06376349 2024-03-31 06376349 core:FurnitureFittingsToolsEquipment 2024-03-31 06376349 core:LandBuildings 2024-03-31 06376349 2023-04-01 2024-03-31 06376349 2024-03-31 06376349 core:ProvisionsDeferredTax 2024-03-31 06376349 core:CurrentFinancialInstruments 2024-03-31 06376349 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 06376349 core:FurnitureFittingsToolsEquipment 2024-03-31 06376349 core:LandBuildings 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 06376349

Prepared for the registrar
Aspire Dental Care Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 31 March 2025

Aspire Dental Care Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 8

Aspire Dental Care Limited

Company Information

Directors | Mr J K Sharma Dr R D Pretorius Dr H Naish

Company secretary | Mr J K Sharma Mr R K Sharma

Registered office | 118 Commercial Road London E1 1NL

Accountants | Hazlewoods LLP Staverton Court Staverton Cheltenham GL51 0UX

Aspire Dental Care Limited

(Registration number: 06376349)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 509,052 | 531,401
Current assets |  |  |
Stocks |  | 6,545 | 3,519
Debtors | 5 | 840,759 | 871,559
Cash at bank and in hand |  | 135,112 | 137,483
|  | 982,416 | 1,012,561
Creditors: Amounts falling due within one year | 6 | (282,835) | (509,651)
Net current assets |  | 699,581 | 502,910
Total assets less current liabilities |  | 1,208,633 | 1,034,311
Deferred tax liabilities | 7 | - | (20,318)
Net assets |  | 1,208,633 | 1,013,993
Capital and reserves |  |  |
Called up share capital |  | 75 | 75
Capital redemption reserve |  | 35 | 35
Revaluation reserve |  | 369,999 | 369,999
Retained earnings |  | 838,524 | 643,884
Shareholders' funds |  | 1,208,633 | 1,013,993

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 31 October 2025 and signed on its behalf by:

Mr J K Sharma
Company secretary and director

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
118 Commercial Road
London
E1 1NL

| 2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.
The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Land and buildings | 0% and 15% straight line
Furniture, fittings and equipment | 20% straight line

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.
The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

| 3 | Staff numbers

The average number of persons employed by the company (including directors) during the year was as follows:

| 2025 No. | 2024 No.
Average number of employees | 18 | 18

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 4 | Tangible assets

| Land and buildings £ | Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 April 2024 | 610,681 | 451,545 | 1,062,226
Additions | - | 5,538 | 5,538
At 31 March 2025 | 610,681 | 457,083 | 1,067,764
Depreciation
At 1 April 2024 | 108,504 | 422,321 | 530,825
Charge for the year | 19,325 | 8,562 | 27,887
At 31 March 2025 | 127,829 | 430,883 | 558,712
Carrying amount
At 31 March 2025 | 482,852 | 26,200 | 509,052
At 31 March 2024 | 502,177 | 29,224 | 531,401

Included within the net book value of land and buildings above is £373,345 (2024 - £373,345) in respect of freehold land and buildings and £109,507 (2024 - £128,832) in respect of long leasehold land and buildings.

| 5 | Debtors

| Note | 2025 £ | 2024 £
Trade debtors |  | 106,195 | 94,524
Receivables from related parties | 8 | 652,877 | 732,821
Prepayments |  | 16,710 | 20,855
Other debtors |  | 64,977 | 23,359
|  | 840,759 | 871,559

| 6 | Creditors

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 8 | - | 154,172
Trade creditors |  | 65,343 | 286,174
Amounts due to related parties |  | 104,858 | 2,000
Taxation and social security |  | 37,557 | 20,959
Accruals and deferred income |  | 6,000 | 4,116
Other creditors |  | 69,077 | 42,230
|  | 282,835 | 509,651

Aspire Dental Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

| 7 | Deferred tax

Deferred tax assets and liabilities

2024 | Liability £
Differences between accumulated depreciation and amortisation and capital allowances | 20,318

| 8 | Related party transactions

Summary of transactions with other related parties

During the year the company received £29,083 (2024 - £99,766) to a related party. At the balance sheet date the amount due from the related party was £703,738 (2024 - £732,821). This amount is interest free and repayable on demand. During the year the company loaned £102,858 (2024 - £Nil) to a related party. At the balance sheet date the amount due to the related party was £104,858 (2024 - £2,000). This amount is interest free and repayable on demand.